Home » Topics » Regulatory

Regulatory
RSS

Metformin XT is equivalent to immediate-release metformin in the treatment of type 2 diabetes

June 27, 2002

Ethypharm and Viatris collaborate on Flashtab formulation of tramadol

June 25, 2002

Australia first to approve Xolair

June 21, 2002

FDA approves Celebrex labeling changes

June 18, 2002

Japanese approval obtained for Elaspol

June 18, 2002

Extina enters phase III for seborrheic dermatitis

June 17, 2002

Zyprexa approved in E.U. for manic episodes associated with bipolar disorder

June 17, 2002

Phase II results announced for Ciprofloxacin GR

June 14, 2002

FDA approves Ritalin LA for ADHD

June 10, 2002

New indications approved for desloratadine in E.U.

June 7, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...